<DOC>
	<DOCNO>NCT00611299</DOCNO>
	<brief_summary>The purpose study investigate dose-response effect increase dos Bifidobacterium animalis ssp lactis ( BB-12 ) Lactobacillus paracasei ssp paracasei ( CRL-431 ) immune response , blood lipid , gut microflora , recovery feces overall tolerance healthy young adult .</brief_summary>
	<brief_title>Dose-Response Study Probiotic Bacteria BB-12 CRL-431 Healthy Young Adults</brief_title>
	<detailed_description>The study include seventy-one healthy young vounteers , design double-blind placebo control dose-response trial base 2 wk run-in period , 3 wk intervention 2 wk wash-out period . The subject randomly assign 5 group 15 subject , supplement 0 , 10E8 , 10E9 , 10E10 10E10 CFU/d , respectively , og mixture BB-12 CRL-431 . Blood sample collect 4 time fecal sample 3 time . Diary reporting bowel habit weel keep 7 week . There article concern issue dose-response effect probiotics.The aim study investigate dose-response effect increase concentration probiotic immune response , blood lipid , composition gut microflora , recovery feces overall tolerance . The hypothesis increase dose would influence immunresponse ( eg incresae phagocytosis ) , improve blood lipid profile ( eg.lower HDL-cholesterol ) , would recover increase concentration feces , would change intestinal microfloraprofile would well tolerate even high dos .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<criteria>Healthy young individual GIdisease Colosomi Pregnant lactate woman Allergy Individuals receive follow medicine : antacid , antibiotic , steroid , medicine influence intestinal function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>Immune response</keyword>
	<keyword>Blood lipid</keyword>
	<keyword>Intestinal microflora</keyword>
	<keyword>Tolerance</keyword>
</DOC>